articles in which miRNA in the urine was used for the detection of BCa. ... Bladder cancer (BCa) is the ninth most commonly ..... 2004; 101: 2999-3004. 12.
Jun 4, 2014 - Using survival analysis and supervised principal components method, we identified an eight-miRNA signature for the prediction of overall ...
Sep 1, 2014 - Article history: ... Forensic serology ... In forensic investigation, body fluids represent an important support to professionals when detected,.
Sep 11, 2012 - of breath pentane are related to adverse outcome and that propofol could ... found between breath pentane levels and survival in the chloral ...
3Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai ...... the International Society for Oncodevelopmental Biology and Medicine 37, ...
Aug 24, 2011 - patients with adrenal incidentalomas, with tumor size, imaging, and even histology all ... Adrenocortical carcinoma (ACC) is a rare tumor but.
May 22, 2012 - ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy. Jong-Mu Sun1â , Ji-Youn Sung2â , Se Hoon ...
May 22, 2012 - incubated in a Bond-max automatic slide stainer (Vision- ..... David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM: Low incidence of.
May 28, 2014 - Stem cell-based therapy for bladder repair is most relevant to congenital ..... or binding scaffolds in the site or using hypoxia as a pre- treatment for ..... Chen VJ, Smith LA, Ma PX: Bone regeneration on computer-designed.
Mar 19, 2014 - Stability of urinary miR-126 and factors that affected the stability were assessed. ... ple, plasma miR-208 has been used as a biomarker of acute.
Jan 4, 2016 - Bladder cancer (BCa) is one of the most common urothelial cancers with still noticeable incidence rate. Early detection of BCa is.
6p22.3 amplification is as twice as high (p=0.0201) in African American (AA) than. European ..... S, Lecerf L, Kouyoumdjian JC, Abbou CC, Pairon JC,. Jaurand ...
University of Groningen. Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal. Tumors. Arlt, Wiebke; Biehl, Michael; Taylor, ...
used as biomarkers for cancer screening. We detected the expression level of miR-155 in the serum of female breast cancer pa- tients and healthy controls to ...
Asian Pacific Journal of Cancer Prevention, Vol 14, 2013 7433 ... Nasopharyngeal carcinoma (NPC) is a rare tumor in most countries. However, it is very ...
Oct 15, 2016 - invasion and positive lymph node metastasis. However, there were ..... [25] Gui Y, Guo G, Huang Y, Hu X, Tang A, Gao S, Wu. R, Chen C, Li X, ...
approximately 95% of ALS cases and 50% of FTD cases, and discovery of this common ... average age of onset being between 45 and 65 years old, and the ...
Most of the studies investigating Mn exposure have analyzed its effects in ... between early life Mn exposures and subsequent adverse neurobehavioral outcomes. ..... levels in these samples could have been affected by the postnatal .... Collipp, P. J
Sep 2, 2018 - psychosis and extra-pyramidal symptoms, respectively. There are .... 21. Abbreviation: uPDRS, unified Parkinson's disease Rating Scale.
A pathological diagnosis (rather than a clinical diagnosis) of FTD is referred to as frontotemporal lobar degeneration. (FTLD). Indeed, three major pathological ...
Jan 19, 2017 - malignant peritoneal mesothelioma were also reported to be significantly higher than those of nonmesothelioma subjects with a history of ...
Jan 31, 2011 - Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube ...
the second most common malignancy in the genitourinary ... in patients with urothelial carcinoma of the urinary bladder were significantly lower than those in ...
to 48 hours at room temperature [21, 22]. The aim of the present ..... NMP22 â nuclear matrix protein 22; UBC â urinary bladder cancer antigen;. CYFRA21-1 ...
177
Central European Journal of Urology
UROLOGICAL ONCOLOGY
REVIEW PAPER
Urine miRNA as a potential biomarker for bladder cancer detection – a meta-analysis Piotr Kutwin1, Tomasz Konecki1, Edyta Marta Borkowska2, Magdalena Traczyk-Borszyńska2, Zbigniew Jabłonowski1 Medical University of Łódź, 1st Department of Urology, Łódź, Poland Medical University of Łódź, Department of Clinical Genetics, Łódź, Poland
1 2
Citation: Kutwin P, Konecki T, Borkowska EM, Traczyk-Borszyńska M, Jabłonowski Z. Urine miRNA as a potential biomarker for bladder cancer detection – a meta-analysis. Cent European J Urol. 2018; 71: 177-185.
Introduction White light cystoscopy (WLC), often supported by urine cytology, is considered the ‘goldstandard’ in the diagnosis and follow-up of bladder cancer (BCa). In recent years, urine microRNA (miRNA) tests have been performed for the detection of bladder cancer. Material and methods A systematic review of the PubMed platform was performed by searching for articles in which miRNA in the urine was used for the detection of BCa. Results The greatest sensitivity (86.6%) in BCa detection was achieved for multi-miRNA in urine sediment. The greatest specificity (85.3%) was achieved for multi-miRNA from voided urine. There were significant differences (p
